Table 3.
Outcome parameters of the study
| All patients | Subgroup: PaO2/FIO2 <150 | |||||
|---|---|---|---|---|---|---|
| avECCO2-R | Control | p | avECCO2-R | Control | p | |
| Ventilator-free-days-28 | 10.0 ± 8 | 9.3 ± 9 | 0.779 | 11.3 ± 7.5 | 5.0 ± 6.3 | 0.033 |
| Ventilator-free-days-60 | 33.2 ± 20 | 29.2 ± 21 | 0.469 | 40.9 ± 12.8 | 28.2 ± 16.4 | 0.033 |
| Non-pulmonary organ failure free days-60 | 21.0 ± 14 | 23.9 ± 15 | 0.447 | 24.1 ± 7.5 | 29.0 ± 17.7 | 0.428 |
| Lung injury score on day 10 | 2.2 ± 0.6 | 2.1 ± 0.5 | 0.854 | 2.3 ± 0.8 | 2.2 ± 0.5 | 0.601 |
| Length of stay in hospital (days) | 46.7 ± 33 | 35.1 ± 17 | 0.113 | 42.0 ± 16.6 | 40.3 ± 15.7 | 0.815 |
| Length of stay in ICU (days) | 31.3 ± 23 | 22.9 ± 11 | 0.144 | 25.9 ± 13.1 | 31.0 ± 12.7 | 0.258 |
| In-hospital mortality | 7/40 (17.5 %) | 6/39 (15.4 %) | 1.000 | 1/21 (4.8 %) | 1/10 (10 %) | 0.563 |